Melínová L, Dienstbier Z, Zámecník J, Hermanská Z, Smakal S, Chytrý P, Maríková E
Katedra a ústav biofyziky a nukleární mediciny 1. lékarské fakulty Univerzity Karlovy, Praha.
Cas Lek Cesk. 1990 Oct 19;129(42):1332-6.
The prognostic importance of mediastinal affection and its extent was analyzed in a group of 220 patients with Hodgkin's disease in all clinical stages. The results of the total survival period in mediastinal patients are significantly worse, as compared with patients without primary affection of the mediastinum at all evaluated time intervals: in the 5th year after onset of treatment 79% vs. 95% in the 10th, 15th and 20th year 67% vs 86%, 63% vs. 86% and 56% vs. 86%. The survival of patients without a mediastinal tumour does not change after a 10-year period of follow-up, in case of a tumour mass up to 1/3 of the transverse chest diameter it declines from 81% in the 5th year to 59 and to 49% in the 10th and 15th year. In case of extensive mediastinal affection only 61% survive 5 years and 42% survive after 10 years. The differences in survival without signs of the disease are not statistically significant, obviously due to primary radiochemotherapy with alternation of cytostatic combinations. There are no significant differences in the frequency of posttherapeutic X-ray changes in the mediastinal area after primary X-ray therapy alone and after chemotherapy alone, as compared with combined radio-chemotherapy with the incidence of postirradiation changes in 30% of the patients: the incidence of post-irradiation changes is potentiated by the administration of bleomycin, depending on the dose. For evaluation of posttherapeutic X-ray changes in the area of the chest it is essential to monitor the patients by X-ray check-ups with concurrent functional examination of the lungs.
对220例处于所有临床分期的霍奇金病患者进行分析,以探讨纵隔受累情况及其范围的预后重要性。在所有评估时间间隔内,纵隔受累患者的总生存期结果明显较差,与无纵隔原发性受累的患者相比:治疗开始后第5年为79%,而无纵隔原发性受累患者为95%;第10年、第15年和第20年分别为67%对86%、63%对86%和56%对86%。无纵隔肿瘤患者的生存率在随访10年后没有变化;若肿瘤肿块达胸部横径的1/3,其生存率从第5年的81%下降至第10年的59%和第15年的49%。若纵隔广泛受累,仅61%的患者能存活5年,42%的患者能存活10年。无疾病迹象的生存率差异无统计学意义,显然是由于采用了细胞毒性联合方案交替进行的原发性放化疗。与单纯放疗后及单纯化疗后相比,单纯原发性放疗后与放化疗联合后纵隔区域治疗后X线改变的频率无显著差异,放疗后改变的发生率为30%:放疗后改变的发生率因博来霉素的使用而增强,具体取决于剂量。为评估胸部区域治疗后的X线改变,通过X线检查同时对肺部进行功能检查来监测患者至关重要。